Biotec Pharmacon ASA (BIOTEC):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Biotec Pharmacon ASA (BIOTEC) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH4672FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Biotec Pharmacon ASA (Biotec Pharmacon) is a bio-pharmaceutical company. The company develops, manufactures and markets immune modulating compounds for the human health sectors and marine enzymes used in molecular biology. It concentrates on research and development of marine gene products and beta-1,3/1,6-glucan formulations. Biotec Pharmacon’s beta-1,3/1,6-glucan is a non-toxic modulator that increases overall immune resistance and health. The company’s products are used in the areas of human medicine including immunotherapy of cancer, general infection prophylaxis, and imbalanced immune responses. Biotec Pharmacon is headquartered in Tromso, Norway.

Biotec Pharmacon ASA Key Recent Developments

May 06, 2013: Biotec Pharmacon Reports Revenue Of NOK5.9m In Q1 2013
Feb 28, 2013: ArcticZymes Receives Acceptance For Patent Application Covering Its Heat-labile DNase Product In South Africa
Feb 18, 2013: ArcticZymes Receives NOK5m Research Grant From Research Council Of Norway
Feb 14, 2013: Biotec Pharmacon Reports Revenue Of NOK21.5m In 2012

This comprehensive SWOT profile of Biotec Pharmacon ASA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Biotec Pharmacon ASA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Biotec Pharmacon ASA – Key Information
Biotec Pharmacon ASA – Overview
Biotec Pharmacon ASA – Key Employees
Biotec Pharmacon ASA – Key Employee Biographies
Biotec Pharmacon ASA – Key Operational Heads
Biotec Pharmacon ASA – Major Products and Services
Biotec Pharmacon ASA – History
Biotec Pharmacon ASA – Company Statement
Biotec Pharmacon ASA – Locations And Subsidiaries
Biotec Pharmacon ASA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Biotec Pharmacon ASA – Business Description
Biotec Pharmacon ASA – Corporate Strategy
Biotec Pharmacon ASA – SWOT Analysis
SWOT Analysis – Overview
Biotec Pharmacon ASA – Strengths
Biotec Pharmacon ASA – Weaknesses
Biotec Pharmacon ASA – Opportunities
Biotec Pharmacon ASA – Threats
Biotec Pharmacon ASA – Key Competitors

Section 3 – Company Financial Performance Charts

Biotec Pharmacon ASA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Biotec Pharmacon ASA, Key Information
Biotec Pharmacon ASA, Key Ratios
Biotec Pharmacon ASA, Share Data
Biotec Pharmacon ASA, Major Products and Services
Biotec Pharmacon ASA, History
Biotec Pharmacon ASA, Key Employees
Biotec Pharmacon ASA, Key Employee Biographies
Biotec Pharmacon ASA, Key Operational Heads
Biotec Pharmacon ASA, Other Locations
Biotec Pharmacon ASA, Subsidiaries
Biotec Pharmacon ASA, Key Manufacturing facilities
Biotec Pharmacon ASA, Key Competitors
Biotec Pharmacon ASA, SWOT Analysis
Biotec Pharmacon ASA, Ratios based on current share price
Biotec Pharmacon ASA, Annual Ratios
Biotec Pharmacon ASA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Biotec Pharmacon ASA, Performance Chart
Biotec Pharmacon ASA, Ratio Charts

★海外企業調査レポート[Biotec Pharmacon ASA (BIOTEC):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Magic Software Enterprises Ltd. (MGIC):企業概要、財務及び戦略的SWOT分析
    Summary Magic Software Enterprises Ltd. (MSEL) is an information technology company. The company provides application platforms and business integration solutions. Its products include smarter technology, Magic xpi integration platform, AppBuilder, Magic xpa application platform and legacy products. …
  • Ayen Enerji A.S. (AYEN):企業概要、財務及び戦略的SWOT分析
    Summary Ayen Enerji A.S. (Ayen Enerji) is a power generation company. The company along with its subsidiaries carries out electricity generation, distribution and trading. It also constructs and manages hydroelectric and wind power plants. Its power plants are located in Res mordogan, buyukduz hepp, …
  • Asarina Pharma AB-製薬・医療分野:企業M&A・提携分析
    Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB is a drug development company that concentrates on the discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cycl …
  • TYRX, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TYRX, Inc. Mergers and Acquisit …
  • FTS International Services, LLC-石油・ガス分野:企業M&A・提携分析
    Summary FTS International Services, LLC (FTSI) is a private oilfield services company. It provides a well completion services, including pressure pumping, wireline and reservoir optimization technologies. The company offers products and services to the exploration and production companies to enhance …
  • The California Institute for Biomedical Research:企業のM&A・提携動向(医療分野)
    Summary The California Institute for Biomedical Research (Calibr) is a not for profit organization that specializes in translational research. It discovers and develops unique therapies for unmet medical needs. It works in collaboration with investigators in industry and academia. The institute cond …
  • Religare Enterprises Limited:企業の戦略・SWOT・財務分析
    SummaryReligare Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • iLOOKABOUT Corporation (ILA):企業概要、財務及び戦略的SWOT分析
    Summary iLOOKABOUT Corporation (iLOOKABOUT) is a visual data intelligence service provider. The company provides geo-coded images to businesses and governments. Its software and services include AVM reports, property reports, geo-spatial imaging, virtual tours, dropzone, image services and image sto …
  • Nisshinbo Holdings Inc. (3105):企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc. (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Risco Energy Investments Pte Ltd.:企業のM&A・提携動向(石油・ガス分野)
    Summary Risco Energy Investments Pte Ltd. (RiscoEnergy) is an energy investment company that acquires, runs, operates, deals, manages, funds and commercialize oil and gas assets. The company undertakes hydrocarbon exploration, development, production, power generation and gas commercialization. It a …
  • Marfrig Global Foods SA:企業の戦略・SWOT・財務分析
    SummaryMarfrig Global Foods SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Bic Camera Inc.:企業概要・SWOT・財務分析
    Summary Canadean's "Bic Camera Inc. : Retail - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company hist …
  • United States Steel Corporation:企業の戦略・SWOT・財務分析
    United States Steel Corporation - Strategy, SWOT and Corporate Finance Report Summary United States Steel Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Quintiles Transnational Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Quintiles Transnational Corp. M …
  • Catalis SE (XAE1):企業概要、財務及び戦略的SWOT分析
    Summary Catalis SE (Catalis) is a provider of technical service. The company provides technical services related to the creation of digital content for the digital media and entertainment industries. Its products include Power Star Golf and Zumba World Party. Catalis also designs and develops electr …
  • Oryzon Genomics S.A.(製薬・医療分野):企業M&A動向
    Summary Oryzon Genomics S.A. (Oryzon) is a biopharmaceutical company. The company develops therapies and biological solutions for cancer and neurodegenerative diseases. It concentrates on the exploitation of biomarkers identified through genomics and proteomics in diagnostics, personalized medicine …
  • Public Storage:企業の戦略・SWOT・財務分析
    SummaryPublic Storage - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Sumitomo Mitsui Banking Corporation:企業の戦略・SWOT・財務分析
    SummarySumitomo Mitsui Banking Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the …
  • Jenoptik AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Jenoptik AG Mergers and Acquisi …
  • Medica Sur SAB de CV (MEDICAB):企業財務及び戦略的SWOT分析
    Summary Medica Sur SAB de CV (Medica Sur) is a healthcare service provider that operates its own hospitals and clinic complexes, and research and diagnostic laboratories. The center’s specialties include clinical pathology laboratory, endoscopy unit, radiotherapy unit, surgery unit short stay, blood …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆